Larvol Delta - BioAge-Labs-Announces-Discontinuation-of-STRIDES-Phase-2-Clinical-Trial-Evaluating-Azelaprag-in-Combination-with-Tirzepatide-for-the-Treatment-of-Obesity

azelaprag (BGE-105) - BioAge Labs

https://www.globenewswire.com/news-release/2024/12/06/2993284/0/en/BioAge-Labs-Announces-Discontinuation-of-STRIDES-Phase-2-Clinical-Trial-Evaluating-Azelaprag-in-Combination-with-Tirzepatide-for-the-Treatment-of-Obesity.html

Dec 6, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next